Does the tumor microenvironment influence radiation-induced apoptosis?

Alistair Hunter1, Andre Hendrikse, Michael Renan

  • 1Radiation Oncology, Department of Radiation Medicine, University of Cape Town and Groote Schuur Hospital, Observatory, Cape Town, South Africa. Alistair@curie.uct.ac.za

Abstract

Insights

Tumor microenvironment factors like hypoxia, low glucose, and acidosis can inhibit radiation-induced apoptosis, potentially reducing radiotherapy effectiveness. Understanding these factors is crucial for improving cancer treatment outcomes.

Area of Science:

  • Oncology
  • Cell Biology
  • Radiotherapy Research

Background:

  • Cytotoxic anti-cancer agents induce apoptosis in both tumor and normal tissues.
  • Tumor microenvironment conditions, including hypoxia, low glucose, and acidosis, can significantly impact treatment efficacy.
  • Apoptosis regulation is critical for determining the therapeutic gain of anti-cancer treatments.

Purpose of the Study:

  • To investigate factors influencing radiation-induced apoptosis in tumors.
  • To understand the impact of tumor microenvironment on apoptotic processes.
  • To determine how hypoxia, low glucose, and acidosis affect radiotherapy outcomes.

Main Methods:

  • Review of existing literature on apoptosis and tumor microenvironment.
  • Analysis of mechanisms by which hypoxia, low glucose, and acidosis modulate apoptosis.
  • Examination of the role of different apoptotic pathways (mitochondrial, SAPK, Fas).

Main Results:

  • Hypoxia can inhibit or modulate radiation-induced apoptosis depending on cell type and timing.
  • Low glucose and energy depletion impair key stages of apoptosis.
  • Acidosis interferes with radiation-induced apoptosis, potentially through cell cycle arrest.

Conclusions:

  • Hypoxia, low glucose, and acidosis are identified as key factors influencing radiation-induced apoptosis.
  • These tumor microenvironment conditions can be detrimental to the effectiveness of radiotherapy.
  • Further research into these factors may lead to improved therapeutic strategies.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...